Pathogenic Serum Amyloid A 1.1 Shows a Long Oligomer-rich Fibrillation Lag Phase Contrary to the Highly Amyloidogenic Non-pathogenic SAA2.2-Reference-Cited by-同舟云学术

Pathogenic Serum Amyloid A 1.1 Shows a Long Oligomer-rich Fibrillation Lag Phase Contrary to the Highly Amyloidogenic Non-pathogenic SAA2.2

Published:2013-01 Issue:4 Volume:288 Page:2744-2755
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Srinivasan Saipraveen,Patke Sanket,Wang Yun,Ye Zhuqiu,Litt Jeffrey,Srivastava Sunit K.,Lopez Maria M.,Kurouski Dmitry,Lednev Igor K.,Kane Ravi S.,Colón Wilfredo

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference53 articles.

1. Serum amyloid A, the major vertebrate acute-phase reactant;Uhlar;Eur. J. Biochem.,1999

2. Serum amyloid A. An acute-phase protein involved in tumour pathogenesis;Malle;Cell. Mol. Life Sci.,2009

3. Amyloid precursors and amyloidosis in rheumatoid arthritis;Cunnane;Baillieres Best Pract. Res. Clin. Rheumatol.,1999

4. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein;Gillmore;Lancet,2001

5. Pathology, diagnosis, and pathogenesis of AA amyloidosis;Röcken;Virchows Archiv.,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key charged residues influence the amyloidogenic propensity of the helix-1 region of serum amyloid A;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-11

2. Authentic hSAA related with AA amyloidosis: New method of purification, folding and amyloid polymorphism;Biophysical Chemistry;2024-10

3. Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis;Neurobiology of Disease;2024-08

4. Elucidation of molecular mechanisms by which amyloid β1–42 fibrils exert cell toxicity;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-08

5. Macrophages and Natural Killers Degrade α-Synuclein Aggregates;Molecular Pharmaceutics;2024-04-18